Membership Update – October 2011

BioNJ welcomes GCA Therapeutics, Ltd., and iBio, Inc., as new Core Members for 2011: GCA Therapeutics, Ltd. GCA Therapeutics, Ltd. (GCAT) is a US-based, specialty pharmaceutical company focusing on in-licensing, acquisition, and marketing of mid- through late-stage drug candidates and technologies from North America and the EU. GCAT applies its expertise and resources in pre-clinical,… Read the full article



Biotechnology Companies in the News – October 2011

Editor’s Note: The home page of the BioNJ website provides an up-to-the-minute headline service where readers can access press releases issued by New Jersey-based biotechnology companies. Go to the “New Jersey Biotechnology Company News” section on the BioNJ home page to read the latest news. Companies wishing to appear in the Biolines Biotechnology Companies in… Read the full article



Call for Nominations: The Dr. Sol J. Barer Award for Vision Innovation and Leadership

BioNJ is seeking nominations for its most prestigious award, The Dr. Sol J. Barer Award for Vision, Innovation and Leadership. Named for Sol J. Barer, PhD, the former Chairman and CEO of Celgene Corporation, and presented at BioNJ’s Annual Dinner Meeting, Awards Program and Networking Event, the award recognizes outstanding biotechnology industry business leaders who… Read the full article